Labs / CDMO: development & manufacturing
AccurEdit Therapeutics
Suzhou, China · accuredit.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
AccurEdit Therapeutics develops in vivo gene editing medicines for severe or life-threatening hereditary and acquired diseases. It is based in China and focuses on RNA synthesis, gene editing, and delivery technologies for product development and commercialization.
Their website has a general contact form; we send your quote request through it.
What they offer
RNA synthesis
Synthesizes mRNAs and gRNAs at research or GMP grade.
Gene editing platform development
Develops editors for the modification of DNA, RNA, and other genetic components.
gRNA design, screening, optimization, and validation
Supports gRNA selection using independently developed algorithms.
Delivery technology development
Develops LNP and polymer-based delivery technologies for liver and other organs.
In vivo gene editing therapy development
Builds end-to-end in vivo gene editing products from early stage to product approval.
What they work on
- Modalities
- Small molecule, Antibody, ADC, mRNA, Cell therapy, Gene editing, LNP / formulation
- Assays and studies
- gRNA screening, gRNA optimization, gRNA validation
- Scale and capacity
- industry-scale platform
- Therapeutic areas
- ATTR, hereditary diseases, acquired diseases
- Sites
- Suzhou, China
- Quality
- ICH guidelines (product development from early stage till product approval)
- Serves
- China, US, worldwide
- Founded
- 2001
Similar labs. Probiocdmo, PROGEN INC, Unchained Labs, Vaxcyte
Found in a contract services directory. Listing built from accuredit.com. Work here? Claim this listing.